ReviewFrontiers in reproductive health2025
Genetic variation associated with side effects of hormonal contraception exposure: a narrative review.
Review in Frontiers in reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hormonal contraceptives (HCs) are commonly prescribed medications that have had immeasurable impacts on quality of life and health of women and families globally. However, usage of exogenous hormones is not without risks, and patients often report a variety of side effects, ranging from burdensome to life-threatening. For some patients, side effects of HCs are severe enough to cause medication discontinuation or switching to alternative forms of contraception. Variability in side effect profiles may indicate heritable risk factors for some side effects. Understanding these patterns or risk profiles may help clinicians anticipate severe adverse events, match patients with suitable medications more rapidly, and improve patient outcomes and adherence. To support further research in this field, this narative review summarizes what is currently known about pharmacogenetic interactions with respect to HCs and specific polymorphisms suspected to contribute to adverse side effects and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.